At present in Ireland access to medicinal cannabis can only be accessed in circumstances where a licence has been granted in respect of an individual. It is expected that under the Medical Cannabis Access Programme cannabis-based medicinal products may be prescribed for certain medical conditions where the patient has failed to respond to standard treatments. Dr. Eric Downer, Associate Professor in Human Health and Disease at Trinity College Dublin and Miriam Haskins, medicinal cannabis patient turned industry insider join RDJ Partner Brian Hunt to discuss the development of medicinal cannabis and the increasing interest in its potential within the healthcare and pharmaceutical sectors.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
